<html>

<head>
<meta content="text/html; charset=utf-8" />


<title>M2950303.DOC;1</title>


</head>

<body>



<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">UNITED STATES </font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SECURITIES AND
EXCHANGE COMMISSION</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">WASHINGTON,
D.C. 20549</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">FORM
8-K</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">CURRENT REPORT
PURSUANT</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">TO SECTION 13 or
15(d) OF THE</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SECURITIES
EXCHANGE ACT OF 1934</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date
of report (Date of earliest event reported): January 18, 2012</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Medytox Solutions, Inc.</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(Exact
Name of Registrant as Specified in Its Charter)</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Nevada</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(State
or Other Jurisdiction of Incorporation)</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="margin-left:0pt;width:0px;">
 <tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">000-54346</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">54-2156042</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Commission File
  Number)</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(I.R.S. Employer
  Identification No.)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">33401</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Address of
  Principal Executive Offices)</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Zip Code)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center><table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(561) 855-1626</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Registrant&#8217;s
  Telephone Number, Including Area Code)</font></p>
  </td>
 </tr>
</table></div>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center><table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">&nbsp;</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Former Name or
  Former Address, if Changed Since Last Report)</font></p>
  </td>
 </tr>
</table></div>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>

<p align=center>__________________________________________________________________________________________</p>


<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;margin-left:58.5pt;text-align:left;text-indent:-58.5pt;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item 1.02.&#160; Termination of Material Definitive
Agreement </font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">As previously
reported, on August 22, 2011 Medytox Institute of Laboratory Medicine, Inc.
(the &quot;Company&quot;), a wholly-owned subsidiary of the registrant, Medytox
Solutions, Inc., entered into an agreement (the &quot;Agreement&quot;) for the
purchase of up to 81% of the issued and outstanding equity ownership of Trident
Laboratories, Inc. (&quot;Trident&quot;) from its shareholders (the
&quot;Selling Shareholders&quot;).&#160; </font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Without any
prior notice, on January 18, 2012, the Company received a notice from Trident
alleging that the Company has not made timely payments of the purchase price
and claiming to rescind the Agreement.&#160; The Company believes it is in full
compliance with all its obligations under the Agreement and disputes that
Trident or the Selling Shareholders had any basis to rescind the Agreement.&#160;
Furthermore, the Company continues to regard the Agreement as being in full
force and effect.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The Company
will aggressively enforce its rights under the Agreement and, if necessary,
seek all available remedies against all parties involved.&#160; On January 20, 2012,
the Company filed a lawsuit in Florida Circuit Court for Broward County against
Trident and the Selling Shareholders for breach of their obligations under the
Agreement and seeking (i) specific performance of the Agreement, (ii) damages
against Trident and the Selling Shareholders for their breach, (iii) a
constructive trust in the Company's favor over Trident and all its assets, (iv)
an accounting of the affairs and accounts of Trident, and (v) damages and an
injunction against Trident and the Selling Shareholders for tortious
interference with business relationships.&#160; </font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The Company
also named as a defendant in the complaint Medical Billing Choices, Inc.
(&quot;Medical Billing&quot;), which is the medical billing company agreed to
by the parties pursuant to the Agreement.&#160; The Company seeks to prevent Trident
and the Selling Shareholders from diverting revenue generated by the Company by
requiring Medical Billing to deposit with the registry of the Court all funds
in dispute pending resolution of the case.</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;margin-left:58.5pt;text-align:left;text-indent:-58.5pt;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;margin-left:58.5pt;text-align:left;text-indent:-58.5pt;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p align=center>__________________________________________________________________________________________</p>


<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SIGNATURES</font></b></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized. </font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date: January 24, 2012&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; MEDYTOX
SOLUTIONS, INC.</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">/s/
William G. Forhan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; William
G. Forhan,</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; CEO,
CFO and Chairman</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (principal
executive officer)</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>



</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "msi8k012412.htm", "secsgml_size_bytes": 17406}]
{"company-data": {"conformed-name": "Medytox Solutions, Inc.", "cik": "0001374536", "assigned-sic": "8734", "irs-number": "542156042", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54346", "film-number": "12542162"}, "business-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401", "phone": "(561) 855-1626"}, "mail-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401"}, "former-company": {"former-conformed-name": "CASINO PLAYERS, INC.", "date-changed": "20060905"}}
M2950303.DOC;1
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 or
15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): January 18, 2012
Medytox Solutions, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
(State
or Other Jurisdiction of Incorporation)
000-54346
54-2156042
(Commission File
  Number)
(I.R.S. Employer
  Identification No.)
400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida
33401
(Address of
  Principal Executive Offices)
(Zip Code)
(561) 855-1626
(Registrant's
  Telephone Number, Including Area Code)
(Former Name or
  Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
__________________________________________________________________________________________
Item 1.02.  Termination of Material Definitive
Agreement
As previously
reported, on August 22, 2011 Medytox Institute of Laboratory Medicine, Inc.
(the "Company"), a wholly-owned subsidiary of the registrant, Medytox
Solutions, Inc., entered into an agreement (the "Agreement") for the
purchase of up to 81% of the issued and outstanding equity ownership of Trident
Laboratories, Inc. ("Trident") from its shareholders (the
"Selling Shareholders").
Without any
prior notice, on January 18, 2012, the Company received a notice from Trident
alleging that the Company has not made timely payments of the purchase price
and claiming to rescind the Agreement.  The Company believes it is in full
compliance with all its obligations under the Agreement and disputes that
Trident or the Selling Shareholders had any basis to rescind the Agreement. 
Furthermore, the Company continues to regard the Agreement as being in full
force and effect.
The Company
will aggressively enforce its rights under the Agreement and, if necessary,
seek all available remedies against all parties involved.  On January 20, 2012,
the Company filed a lawsuit in Florida Circuit Court for Broward County against
Trident and the Selling Shareholders for breach of their obligations under the
Agreement and seeking (i) specific performance of the Agreement, (ii) damages
against Trident and the Selling Shareholders for their breach, (iii) a
constructive trust in the Company's favor over Trident and all its assets, (iv)
an accounting of the affairs and accounts of Trident, and (v) damages and an
injunction against Trident and the Selling Shareholders for tortious
interference with business relationships.
The Company
also named as a defendant in the complaint Medical Billing Choices, Inc.
("Medical Billing"), which is the medical billing company agreed to
by the parties pursuant to the Agreement.  The Company seeks to prevent Trident
and the Selling Shareholders from diverting revenue generated by the Company by
requiring Medical Billing to deposit with the registry of the Court all funds
in dispute pending resolution of the case.
__________________________________________________________________________________________
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Date: January 24, 2012                                               MEDYTOX
SOLUTIONS, INC.
/s/
William G. Forhan
William
G. Forhan,
CEO,
CFO and Chairman
(principal
executive officer)